QTX-2101 Awarded FDA Fast Track Designation for the Treatment of Acute Promyelocytic Leukemia
CHICAGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company…
Samsung Outlines the Impact FAST, Creators and Live Experiences Are Having on the Future of Television at CES 2026
Samsung Tech Forum series continues at CES 2026 with industry leaders convening…
ST Engineering iDirect CTO Sridhar Kuppanna Named CTO of the Year by The Fast Mode
HERNDON, Va., Dec. 9, 2025 /PRNewswire/ -- ST Engineering iDirect, a global leader…
MainStreaming has been officially recognized as a winner in the “Edge Tech Champion” category at The Fast Mode Awards 2025
MILAN, Dec. 11, 2025 /PRNewswire/ -- MainStreaming, the award-winning and innovative Edge…
Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI
New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom…
CCTV+: CMG launches 3 specialized FAST channels, reaching 200 million global viewers
BEIJING, Nov. 6, 2025 /PRNewswire/ -- China Global Television Network (CGTN), China…
Safe Online Casinos USA for 2025: BetWhale Rises as the Fast Payout Real Money Online Casino
Los Angeles, California, Nov. 01, 2025 (GLOBE NEWSWIRE) -- BetWhale is a…
TraceLink Recognized on Fast Company’s Next Big Things in Tech List
The annual list honors groundbreaking advancements redefining the way we work and…
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and…
Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program
SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in…
